Controlling cardiovascular diseases in low and middle income countries by placing proof in pragmatism

Mayowa Owolabi1, Jaime J Miranda2, Joseph Yaria3

  • 1Department of Medicine, University of Ibadan, and University College Hospital, Ibadan, Nigeria; World Federation for Neurorehabilitation-Blossom Specialist Medical Center, Ibadan, Nigeria.

BMJ Global Health
|November 15, 2016
PubMed

Insights

Cardiovascular disease (CVD) disproportionately affects low and middle-income countries (LMICs). This study presents an implementation cycle and translatability scale to guide CVD prevention and treatment strategies in resource-limited settings.

Area of Science:

  • Public Health
  • Implementation Science
  • Cardiovascular Medicine

Background:

  • Low and middle-income countries (LMICs) face a significant and increasing burden of cardiovascular disease (CVD).
  • Limited resources and lack of pragmatic guidelines hinder effective CVD prevention, treatment, and rehabilitation in LMICs.
  • Addressing the global CVD burden requires tailored strategies for LMICs.

Purpose of the Study:

  • To present an implementation cycle for developing, contextualizing, communicating, and evaluating CVD recommendations for LMICs.
  • To introduce a translatability scale for assessing the ease of implementing CVD recommendations in resource-limited settings.
  • To provide strategies for stakeholder engagement and feedback enhancement in CVD management.

Main Methods:

  • Development of an implementation cycle framework for CVD recommendations.
  • Creation of a translatability scale to rank recommendation implementability.
  • Prescription of stakeholder engagement strategies (providers, patients, policymakers).
  • Formulation of feedback enhancement mechanisms.

Main Results:

  • The proposed implementation cycle offers a structured approach to adapt and apply CVD guidelines in LMICs.
  • The translatability scale aids in prioritizing feasible CVD interventions.
  • Stakeholder engagement strategies facilitate the practical application of recommendations.
  • Feedback mechanisms promote continuous improvement in CVD care.

Conclusions:

  • This implementation cycle and translatability scale can help LMICs combat CVD despite resource constraints.
  • The approach can stimulate new hypotheses and research in implementation science for CVD.
  • Effective CVD management in LMICs is achievable through tailored, resource-aware strategies.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
790
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
800
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
445
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
486